Wow, if you're correct, a number of us might buy you steak dinner, at an establishment of your choice, airfare included! :)
Very well stated, Mark. Your percentages are exactly in line with those I have mentioned earlier.
Engineered immunological fighting of cancer is still in its infancy. There will be failures along the way, but most of us have hope for the ultimate goal of defeating cancer. Inovio's pipeline is broad, and that should help to de-risk part of the P2 data readout. It's a quasi-binary event, as another poster pointed out. But in the name of cancer, I hope it's a positive event.
Even with failure, the sun will still shine and Inovians will live to fight another day. But the trial has a very good chance of success, IMHO. We'll learn soon enough.
Definitely counterproductive, if your'e trying to promote a stock you're following or interested in.
I've never understood why they do that... unless it's as you say, to divert attention from the science and the results.
Knock of what? We're talking about you now.
We thought you liked the attention, posting 24x7x365 here.
This isn't about ethnicity now, it's about you, or whatever you're trying to represent virtually through your alias. That's the real mystery here.
Glad you accepted my apology to you, Regrose. Many thanks.
That movie is pretty intense, very long, sometimes brutal, but always interesting. I've watched it several times and have gotten more out of it each time.
I never run out of things to do in D.C. There are so many places to see, things to do. I love it there in the Spring, when the cherry blossoms are blooming. Strikingly beautiful.
I dare you to talk about attacking. harry, you have been incessantly attacking anyone who aligns with Inovio's humanistic goals. You could care less about saving lives. You're simply a hypocrite, who can type.
That is what is known about you. Your alias, your ethnicity, your sex, everything else is unknown, and you'll get little comfort in understanding what you say is actually believed--by anyone.
I'm not sure what the acronym #$%$ refers to, but I'll leave that up to interpretation of every poster who has been offended by you on this board, other boards, and in real life. Oh, and Dr. Kim, too. Take all of that to your bank.
For the record, I'm not an anti-Semite. I'm of Scottish, Irish, and English descent.
Very sorry if you are offended. Please accept my apology.
You may go after my ethnicity in any way that you deem fit, as long as it fits within the constraints of the Investment and Financial community. Fair and balanced.
Again, I was not singling you out in any way. Sorry if you felt offended.
The biggest damage was done by AF. That's what led to my earlier rant.
The short-sellers were getting hammered until AF stepped in and saved their #$%$. He was the catalyst. Without the head, the snake dies.
I just read Stifel's 27-page investment report on Inovio.
They strongly believe that HPV P2 will be a success and have a target price of $16.
Interestingly enough, they are among the most conservative houses out there and have priced very conservatively. So I consider $16 to be on the low end if the trial meets its endpoints.
Well, harry, since you couldn't tell us ANYTHING about the science behind Inovio, the group hereby discredits your opinions in their entirety. You don't get $200, you don't get a free pass, and you don't "pass go."
Please take your parasitic intentions to another board and rinse and repeat elsewhere. Your stench is rather nauseating.
Dr. Weiner co-founded VGX Pharmaceuticals, which merged with Inovio in 2009.
He is part of the scientific community and should not be compared in any way to someone in the financial community like Bernie Madoff.
If they "pay" a basher $500 a week to make $50,000 profit. It's worth it.
Son, you just contradicted yourself BIGTIME.
In previous posts, you indicated that you "liked the science." But the bottom line is that you "hate the science," even though you can't even effectively speak to it. You're sounding more and more like AF, the clown. Perhaps you are his prodigy.
I'm not referring to the scientific community. I'm referring to the financial community (e.g. banks, hedge funds, etc.).
Again, your habit of deflecting attention to an unrelated topic doesn't fly here, junior. Strawman arguments are not allowed. If you'd like to debate in person, I'll undress and expose you for all to see. Get it?
Now, back to the science. "What" do you like about it. Can you even speak to it? Impress us.
That shows your inexperience and lack of information.
The "new" Inovio was formed in 2009. It took the best of both companies to build the platform they have now. One company had great vaccines, and the other had a good delivery system. Now Inovio has both. I'll leave it as an exercise for you to determine who those two companies were which merged to form the "present-day" Inovio, NOT the one which existed 34 years ago.